About 6.6 million influenza-associated illnesses, 3.2 million medically attended illnesses, and 79,000 hospitalizations during the 2012-13 flu season were prevented by flu vaccinations.
Retrophin announced it has signed an agreement with Novartis for an exclusive license for Syntocinon (oxytocin) Nasal Spray.
The FDA has approved the first generic versions of Cymbalta (duloxetine delayed-release) capsules.
Cadence announced positive results from a study assessing the impact of Ofirmev (acetaminophen) injection on certain healthcare-related outcomes in the perioperative setting.
The FDA announced its plan to help phase out the use of medically important antimicrobials in food animals for food production, and to phase in veterinary oversight of the remaining appropriate therapeutic uses.